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Abstract The further biochemical characterization and sub-
cellular localization of cardiotin, a high molecular weight (300 
kDa) constituent of cardiac muscle, is described. Immunofluo-
rescence assays revealed a colocalization of cardiotin and the 
Ca2+ pump SERCA2a in the longitudinal sarcoplasmic reticulum 
(SR). However, in contrast to SERCA2a, cardiotin is not 
detected in the junctional SR. Differential centrifugation 
experiments show that cardiotin cosediments with the micro-
somal fraction of swine heart, while differential extraction 
demonstrates that cardiotin is associated with the SR mem-
branes. In the SR enriched cell fraction a 60 and a 100 kDa 
protein band are detected. Microsequence analyses of these two 
fragments showed a common amino-terminus of 14 amino acids, 
with great homology to amino acid positions 11-24 of human 
skeletal muscle a-actinin. Second generation antibodies directed 
to these specific fragments show the typical cardiotin pattern in 
cardiomyocytes and cross-reactivity amongst the respective 
antigens. Cardiotin did not colocalize with a-actinin, and a-
actinin could not be detected in the microsomal SR fraction. 
Cardiotin therefore represents a new SR associated constituent. 
© 1997 Federation of European Biochemical Societies. 
Key words: Myocardium; Microsomal fraction; oc-Actinin; 
SERCA2a 
1. Introduction 
The sarcoplasmic reticulum (SR) of cardiac muscle is a 
complex membranous network, which regulates the contrac-
tion-relaxation cycle of cardiac muscle by rapidly releasing 
and reaccumulating Ca2+ ions [1]. The SR of the mammalian 
myocardium is composed of at least three different structures : 
(1) the longitudinal SR, (2) the junctional SR, and (3) the 
non-junctional SR [2]. The longitudinal SR is formed by a 
network of tubules surrounding the myofibrils. This network 
serves as an intracellular Ca2+ storage site [3]. The junctional 
SR is composed of cisternae which are continuous with the 
longitudinal SR at one end and are in contact with the T-
tubules at the other end. The non-junctional SR, also called 
corbular SR, represents extensions of the longitudinal SR 
confined to the I-band of the sarcomere. 
Physiological and biochemical studies show a sparse SR 
network in fetal heart [4,5]. The rate and extent of Ca2+ up-
take, as well as Ca2+-dependent ATPase activities are substan-
tially lower in fetal SR as compared to neonatal and adult SR 
[6]. From these studies it was concluded that SR matures 
around birth. It has also been suggested that some of the 
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developmental and age-related changes in the myocardial con-
tractility result from alterations in SR properties. The major 
SR-associated proteins have been isolated and their primary 
structures determined. Most of these proteins have isoforms 
and each isoform is expressed in a tissue specific manner [1,2]. 
For example, the sarco/endoplasmic reticulum Ca2+-ATPase 
(SERCA), a family of 100 kDa proteins, are major compo-
nents of SR involved in the Ca2+ uptake, located in the mem-
brane of the longitudinal reticulum and the nonjunctional 
regions of the terminal cisternae. This SR/ER Ca2+ pump 
exists as multiple isoforms, identified at the DNA level. The 
five different isoforms known so far are encoded by three 
different genes [2]. Other SR-related proteins found in the 
cardiac SR vesicles are the regulatory proteins phospholam-
ban and the acidic Ca2+ binding protein calsequestrin. The 
latter is located in the luminal space of junctional and corb-
ular SR and not in the lumen of the longitudinal network 
(review: [1,2]). 
Previously, we have identified a high molecular weight pro-
tein that was designated cardiotin because of its apparent 
specificity for cardiac muscle [7]. Using a monoclonal anti-
body, cardiotin was found to be located longitudinally be-
tween the myofibrils, perpendicular to the sarcomeric cross-
striation patterns, and to be absent in the intercalated disk. 
Cardiotm is detected with the monoclonal antibody R2G in 
the myocardium only after birth and was found in several 
species ranging from Xenopus laevis to man. Under patholog-
ical conditions, for example chronic ischemie myocardium, the 
cardiotin distribution is affected [8]. Its subcellular location 
and age-related expression pattern indicated to us that cardi-
otin may be related to the SR. In this study we further char-
acterize cardiotin and demonstrate its association with the SR. 
2. Materials and methods 
2.1. Preparation and analysis of microsomal fractions 
The microsomal fraction, including SR vesicles, was prepared from 
fresh frozen swine heart by the following method. About 10 g of heart 
muscle, cleaned of fat and connective tissue, was minced into small 
pieces, and homogenized with 50 ml buffer (5 mM Tris-HCl pH 7.4, 
2 mM EDTA, and 8.5% sucrose) with a Potter homogenizer. The 
homogenate was passed through two layers of cheesecloth and buffer 
was added up to 50 ml. The filtrate was centrifuged at 1000 Xg for 10 
min and a sample from this first pellet, the so-called cytoskeletal 
fraction, was frozen at —20°C. The supernatant was centrifuged for 
15 min at 9000Xg, and the resulting supernatant again twice for 15 
min at 20000Xg. SR vesicles present in this latter 20000Xg super-
natant were subsequently pelleted by a 1 h HOOOOXg spin. The pellet 
was resuspended in 500 ul PBS. All centrifugation steps were per-
formed at 0°C. 
For further protein extraction studies of the microsomal fraction, 
equal amounts of the final SR fraction were again spun down at 
HOOOOXg for 15 min and the pellets were resuspended in either 1.0 
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M KC1/0.25 M sucrose, or 200 mM Na 2 C0 3 (pH 11.5). After a 30 
min incubation on ice, samples were centrifuged at HOOOOXg for 15 
min [9,10]. Cardiotin, SERCA2a and a-actinin were detected by West-
ern blot analyses. 
2.2. Gel electrophoresis and immunoblotting 
For gel electrophoretic analyses the SR samples were dissolved in 
3 volumes of SDS sample buffer [11] with or without reducing agent, 
i.e. ß-mercaptoethanol or dithiothreitol (DTT). Polyacrylamide (PAA) 
SDS gel electrophoresis and immunoblotting of the SR membrane 
fractions were carried out essentially as described [7,12]. For the de-
tection of cardiotin and SERCA2a the chemiluminescence method 
was used (ECL-kit, Amersham International, Amersham, UK). Des-
min and a-actinin were detected with horseradish peroxidase conju-
gated immunoglobulins (DAKOpatts, Glostrup, Denmark) and 4-
chloro-1-naphthol (Merck, Dassel, Germany) [7]. 
2.3. Protein microsequencing analysis 
SR proteins were separated on polyacrylamide SDS gels. After elec-
troblotting onto PVDF membranes (Problott; Applied Biosystems, 
Foster City, CA, USA) using 10 mM CAPS buffer (3-[cyclohexylami-
no]-l-propane sulfonic acid) pH 11, and 10% methanol, proteins were 
revealed by Ponceau staining and the bands of interest excised. Pro-
teins that were selected for the microsequencing procedure were iso-
lated from the PVDF membranes. Detection of the appropriate band 
was done on blot strips using the monoclonal cardiotin antibody 
R2G. Amino-terminal sequencing was performed in a blot cartridge 
on a type 47IB Sequencer (Applied Biosystems), operated in the 
pulsed-liquid mode as recommended by the manufacturer. The ob-
tained sequences were aligned with sequences stored in the SwissProt 
and EMBL databank. 
2.4. Immunocytochemistry and antisera 
Double-label immunofluorescence staining procedures were per-
formed on 5 urn thick cryostat sections of swine heart as described 
before [7]. The following antibodies were used in this study: (1) the 
mouse monoclonal antibody R2G directed to cardiotin [7]; (2) the 
mouse monoclonal antibody cardio-1511 directed to the 100 kDa 
subunit of cardiotin; (3) the mouse monoclonal antibody cardio-224 
directed to the 60 kDa subunit of cardiotin; (4) a polyclonal rabbit 
antiserum directed to SERCA2a [13]; (5) a polyclonal rabbit antise-
rum directed to a-actinin (a653); (6) the mouse monoclonal antibody 
RD301 directed to desmin [7]. 
Second generation monoclonal antibodies SR-2 and SR-3 were 
raised against the 100 kDa and 60 kDa cardiotin constituents, respec-
tively. Female BALB/c mice were subjected to intrasplenic immuniza-
tion with small nitrocellulose strips containing either the 100 kDa or 
the 60 kDa cardiotin constituent. After the immunization period of 
4 weeks, spleen cells were fused with Sp2/0-Agl4 myeloma cells, 
cloned and grown according to standard protocols [7,14]. Cardiotin 
Fig. 2. Polyacrylamide SDS gel electrophoresis and immunoblotting 
of the microsomal (HOOOOXg) fraction of swine heart (lanes 1-5) 
and the cytoskeletal fraction of swine heart (lane 6). Lanes 1 and 2: 
Samples run without reducing agents. Lanes 3-6: Samples prepared 
with ß-mercaptoethanol. Lanes M, 1, 3: Page blue 83 stained 10% 
polyacrylamide SDS gels of molecular weight markers (lane M), and 
the microsomal swine heart sample (lanes 1 and 3). Lanes 2 and 4: 
Immunoblots of the microsomal swine heart samples incubated with 
the monoclonal cardiotin antibody (R2G). Lane 5: Detection of 
SERCA2a (100 kDa) in the microsomal swine heart fraction with a 
polyclonal antiserum. Lane 6: Immunoblot incubated with the 
monoclonal antibody to desmin (RD301; 53 kDa) and a polyclonal 
antiserum to a-actinin (a653; 110 kDa). 
specific monoclonal antibodies were selected on the basis on their 
staining pattern in human myocardium sections and their specific 
reactivity with the 100 kDa and 60 kDa bands in immunoblots. 
3. Results 
Cardiotin, a high molecular weight component expressed in 
Fig. 1. Immunoblotting of the enriched microsomal fraction (SR) 
and the cytoskeletal fraction (CSK) of swine heart, incubated with 
the monoclonal cardiotin antibody R2G (lane 1), the polyclonal 
SERCA2a antibody (lane 2) and a polyclonal antibody directed to 
a-actinin (lanes 3 and 4). 
Fig. 3. Immunoblotting of the microsomal swine heart fraction 
treated with 1 M KC1 (lanes 1 and 2) and 200 mM Na 2C0 3 , pH 
11.5 (lanes 3 and 4), and thereafter separated into a pellet (p) and 
supernatant (s) fraction by centrifugation at 4°C and HOOOOXg for 
15 min. After polyacrylamide SDS gel electrophoresis and immuno-
blotting of these samples a monoclonal antibody to cardiotin (R2G) 
and a polyclonal antiserum to SERCA2A were used for detection 
of the respective proteins. 
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SHC 1 N Y V Y E D D E Y N I Q E E 1 4 
HSM 1 1 N Y V Y D E D E Y M I Q E E 2 4 
CSM 1 4 T Y N Y E E D E Y M T Q E E 2 7 
DSM 7 L S M E Y G D G Y M E Q E E 2 1 
Fig. 4. Sequence alignment of the N-termini of swine heart cardiotin 
(SCH), human skeletal muscle a-actinin (HSM), chicken skeletal 
muscle a-actinin (CSM) and Drosophila skeletal muscle a-actinin 
(DSM). Homologous regions are indicated by bold letters. The se-
quence data are available from EMBL/Genbank. 
postnatal cardiomyocytes of several species, exhibits a char-
acteristic distribution pattern when analyzed with the mono-
clonal antibody R2G. The localization of cardiotin in a lon-
gitudinal fashion between the cardiomyofibrils [7], the age-
related cardiotin expression [7], and the down-regulation of 
cardiotin in chronic ischemie myocardium [8] suggested a re-
lation of this protein with the longitudinal SR. 
3.1. Cardiotin is found in the SR fraction of swine heart 
Using immunoblotting assays with the monoclonal cardio-
tin antibody R2G, a high molecular weight protein band of 
300 kDa was localized to the microsomal fraction of swine 
heart (Fig. 1, lane 1). This microsomal sample contains the 
cardiac SR vesicles as indicated by the presence of SERCA2a 
at 100 kDa (Fig. 1, lane 2). No desmin or a-actinin (Fig. 1, 
lane 3) could be detected in this microsomal fraction. In con-
trast, these muscle specific proteins were found in the cyto-
skeletal fraction at molecular weights of 53 and 110 kDa, 
respectively (Fig. 1, lane 4 and Fig. 2, lane 6). The 300 kDa 
protein was detected in the enriched SR fraction (Fig. 2, lane 
2) only when no reducing agents, i.e. ß-mercaptoethanol or 
dithiothreitol (DTT), were added to the SDS sample buffer. 
When SDS sample buffer containing these reducing agents 
was used, two major protein bands at the 100 kDa and 60 
kDa molecular weight level were detected with the cardiotin 
specific monoclonal antibody R2G (Fig. 2, lane 4). In this 
latter sample no 300 kDa protein band was detected in the 
R2G immunoblot. The additional, weakly positive bands in 
the immunoblots most probably represent breakdown prod-
ucts of cardiotin, although non-specific staining reactions can-
not be excluded. 
As shown in Fig. 3 cardiotin and SERCA2a cannot be 
removed from the SR fraction after incubation with 1.0 M 
KC1/0.25 M sucrose. After re-centrifugation, cardiotin and 
SERCA2a could only be detected in the pellet fraction, and 
not in the supernatant. However, after treatment of the micro-
somal fraction with 200 mM Na2CC>3 (pH 11.5), cardiotin was 
detected both in the supernatant and in the pellet fraction 
(Fig. 3). This contrasts with SERCA2a, which was exclusively 
found in the pellet fraction and not in the supernatant. 
3.2. Microsequencing analysis 
The two immunopositive cardiotin protein bands (100 and 
60 kDa), were subjected to NH2-terminal sequencing, result-
ing in amino acid sequence NYVYEDDEYMIQEE for both 
protein bands. When aligned with sequences in the SwissProt 
and EMBL databank the amino-terminal sequence of cardio-
tin revealed a high homology to human skeletal muscle a-
actinin amino acid positions 11-24 (Fig. 4). Furthermore, 
partial homology was revealed with the conserved C-terminal 
region of chicken and Drosophila a-actinin. 
3.3. Immunolocalization of cardiotin, SERCA2a, and 
a-actinin 
The monoclonal cardiotin antibody R2G reacts strongly 
with the longitudinal SR of swine heart muscle cells (Fig. 
5A,C). No reaction was seen in the junctional SR, while 
also no reactivity was detected in stromal cells and blood 
vessels. Using the polyclonal rabbit antiserum directed to 
SERCA2a, a staining reaction comparable to that of R2G 
was found with the longitudinal SR (Fig. 5B). In contrast to 
the R2G staining pattern however, an additional cross-stria-
tion pattern was seen in the muscle cells with the SERCA2a 
antiserum, in accordance with its localization to the junctional 
SR. With the a-actinin polyclonal antiserum a clear and ex-
clusively cross-striated pattern was detected (Fig. 5D), in ac-
cord with its Z-line association in the sarcomeres. 
Fig. 5. Double-label immunofluorescence microscopy of swine heart tissue incubated with the monoclonal antibody to cardiotin (A and C) and 
simultaneously with the polyclonal antisera to SERCA2a (B) and a-actinin (D). Bars indicate 5 um. 
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Fig. 6. Immunofluorescence microscopy of human heart tissue incubated with the monoclonal antibody SR-2 raised against the 100 kDa cardi-
otin subunit (A), and the monoclonal antibody SR-3 raised against the 60 kDa cardiotin subunit (B). Immunoblotting of the microsomal swine 
heart fraction prepared and separated in the presence of ß-mercaptoethanol revealed the 100 kDa and 60 kDa constituents after incubation 
with SR-2 (C), SR-3 (D), and R2G (E). Bars indicate 5 urn. 
3.4. Second generation monoclonal antibodies directed to 
cardiotin subunits 
Since the 60 kDa and 100 kDa cardiotin fragments ap-
peared to be related immunologically, have identical amino-
termini, and represented the most prominent bands in the 
immunoblots, these two cardiotin constituents were selected 
for further analysis. For this purpose we generated mouse 
monoclonal antibodies directed to these specific constituents 
by intrasplenic immunization of mice with nitrocellulose strips 
containing the 60 kDa or the 100 kDa cardiotin immunopos-
itive protein band. After screening on tissue sections and 
Western blots cardiotin specific monoclonal antibodies were 
selected, i.e. SR-2 and SR-3. In immunofluorescence assays on 
cryostat sections of myocardium both monoclonal antibodies 
show the characteristic cardiotin staining pattern in cardio-
myocytes (Fig. 6A,B). In immunoblotting of proteins sepa-
rated under reducing conditions, SR-2 and SR-3 are both 
reactive with the 60 kDa and the 100 kDa cardiotin subunits 
of the SR-enriched fraction of swine heart tissue (Fig. 6C,D). 
When proteins were separated under non-reducing conditions, 
both new antibodies reacted with the 300 kDa protein (not 
shown). 
4. Discussion 
Previously, we have described the specific expression of the 
high molecular weight protein cardiotin in heart muscle cells 
of different species as identified by a monoclonal antibody [7]. 
The immunolocalization studies suggested a relation of cardi-
otin with the SR, while also its expression pattern parallelled 
SR maturation in cardiomyocytes around birth [4,5]. Also 
during cardiac contractile dysfunction, a decreased SR activity 
is described (review: [15]). The initiation of expression of car-
diotin only after birth [7], and the disappearance of cardiotin 
in affected cells of the chronic ischemie myocardium [8] were 
in accordance with the suggested relation of cardiotin to the 
SR. 
4.1. Cardiotin is located in the SR 
In the underlying study we have compared the subcellular 
localization of cardiotin to the muscle specific sarco/endoplas-
mic reticulum Ca2+-ATPase SERCA2a using immunofluores-
cence assays as well as differential centrifugation and extrac-
tion procedures. The Ca2+-ATPase is uniformly distributed 
throughout the SR network, i.e. in the longitudinal SR and 
in the junctional SR of the cardiomyocytes [2]. Colocalization 
of SERCA2a and cardiotin was found only in the longitudinal 
SR. 
The presence of a high molecular weight (300 kDa) band 
immunoreactive with R2G in the highly enriched microsomal 
fraction of swine heart endorses the relation of cardiotin with 
the SR. In this fraction, containing the SR membranes [16], 
also the Ca2+-ATPase SERCA2a was detected, while other 
major SR-related proteins, such as phospholamban, calse-
questrin and calreticulin are also present in this fraction as 
described before (review: [1]). Cardiotin was not released from 
the SR vesicles after treatment with high salt buffers suggest-
ing that the protein (complex) is not electrostatically associ-
ated with the cytoplasmic side of the SR vesicles [9,10,17]. 
After extraction with 200 mM Na2CC>3, cardiotin was only 
partly released from the SR. Since the microsomes are per-
meabilized by Na2CC>3 to release intraluminal SR proteins 
[9,18], this result indicates a strong association of part of 
the cardiotin with the luminal side of the SR. 
Also preliminary data from studies with proteolytic en-
zymes, applied to the microsomal fraction of heart muscle, 
suggest a protection of cardiotin, in accordance with its ap-
parent intraluminal localization in the SR (unpublished). The 
fact that cardiotin is (partially) retained in the SR after Triton 
X-100 extraction of the tissue sections also supports the idea 
that the molecule is strongly associated with this membrane 
fraction. 
4.2. Putative structure of cardiotin 
SDS gel electrophoresis of cardiac SR without reducing 
agents and subsequent immunodetection revealed a molecular 
weight of approximately 300 kDa for cardiotin. The use of 
reducing agents in these gel electrophoretic analyses resulted 
in two immunoreactive fragments of 100 kDa and 60 kDa. 
Additional evidence that these constituents represent cardio-
tin-related subunits comes from the fact that separate immu-
nization of mice with these two distinct cardiotin subunits 
resulted in two second generation monoclonal antibodies 
which cross-reacted with the 300, 100 and 60 kDa proteins. 
These new monoclonal antibodies exhibit the typical SR stain-
ing pattern in immunofluorescence assays of heart tissue. 
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Therefore it is hypothesized that the cardiotin molecule appa-
rently consists of a tetrameric configuration of two 100 kDa 
and two 60 kDa molecules interacting by S-S bridges. 
Sequence analysis of the 100 kDa and 60 kDa fragment 
showed that both subunits contain the same amino-terminal 
14 amino acid sequence, showing a high homology to part of 
the actin binding domain of a-actinin [19-22]. The N-terminal 
sequences of both cardiotin subunits show a high homology 
to human skeletal muscle a-actinin and also partial homology 
with chicken and Drosophila skeletal muscle a-actinin. The 
conserved nature of this region indicates its importance and 
suggests that both cardiotin subunits have an actin binding 
domain, like skeletal muscle a-actinin. This also suggests that 
the tetrameric cardiotin protein structure may be a transmem-
brane complex with the N-terminus at the cytoplasmic side of 
the membrane, able to interact with actin, and the C-terminus 
at the SR-luminal side. The fact that the cardiotin subunits 
share the a-actinin-like N-terminal sequence, as well as the 
R2G epitope, strongly indicates that both constituents are 
either encoded by alternatively spliced transcripts of one 
gene, result from the use of different promoters or alterna-
tively are modified differentially after translation. 
In conclusion, this study shows immunocytochemically and 
biochemically that cardiotin is associated with the SR. The N-
terminal sequences of the 100 kDa and 60 kDa cardiotin 
subunits show high homology to the actin binding domain 
of skeletal muscle a-actinin. Such a sequence has so far not 
been detected in SR associated constituents, and therefore 
shows that cardiotin represents a so far unknown SR protein. 
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